Reference:
1. WHO. Cardiovascular diseases (CVDs) . 2017; Available from:
https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
2. Mechanic, O.J. and S.A. Grossman, Acute Myocardial Infarction .
2019, StatPearls Publishing.
3. Carville, S.F., R. Henderson, and H. Gray, The acute management
of ST-segment-elevation myocardial infarction. Clinical medicine
(London, England), 2015. 15 (4): p. 362-367.
4. Shi, W.Y. and J.A. Smith, Role of Coronary Artery Bypass
Surgery in Acute Myocardial Infarction . 2018, Springer.
5. Raghavan, R., B.S. Benzaquen, and L. Rudski, Timing of bypass
surgery in stable patients after acute myocardial infarction. The
Canadian journal of cardiology, 2007. 23 (12): p. 976-982.
6. Werner, N., G. Nickenig, and J.-M. Sinning, Complex PCI
procedures: challenges for the interventional cardiologist. 2018.107 (2): p. 64-73.
7. Caceres, M. and D.S. Weiman, Optimal timing of coronary artery
bypass grafting in acute myocardial infarction. Ann Thorac Surg, 2013.95 (1): p. 365-72.
8. Goldfarb, M., et al., Outcome Reporting in Cardiac Surgery
Trials: Systematic Review and Critical Appraisal. Journal of the
American Heart Association, 2015. 4 (8): p. e002204-e002204.
9. Spadaccio, C. and U. Benedetto, Coronary artery bypass grafting
(CABG) vs. percutaneous coronary intervention (PCI) in the treatment of
multivessel coronary disease: quo vadis? -a review of the evidences on
coronary artery disease. Annals of cardiothoracic surgery, 2018.7 (4): p. 506-515.
10. Bundhun, P.K., C.M. Yanamala, and F. Huang, Percutaneous
Coronary Intervention, Coronary Artery Bypass Surgery and the SYNTAX
score: A systematic review and meta-analysis. Scientific reports, 2017.7 : p. 43801-43801.
11. Baig, K., et al., Does coronary artery bypass grafting improve
quality of life in elderly patients? Interactive cardiovascular and
thoracic surgery, 2013. 17 (3): p. 542-553.
12. Stone, G.W., et al., Five-Year Outcomes after PCI or CABG for
Left Main Coronary Disease. N Engl J Med, 2019. 381 (19): p.
1820-1830.
13. Chang, M., et al., Comparison of Outcome of Coronary Artery
Bypass Grafting Versus Drug-Eluting Stent Implantation for
Non–ST-Elevation Acute Coronary Syndrome. 2017. 120 (3): p.
380-386.
14. Ngaage, D.L., F. Sogliani, and A. Tang, Early and late
prognostic implications of coronary artery bypass timing after
myocardial infarction. European Journal of Cardio-Thoracic Surgery,
2012. 43 (3): p. 549-554.
15. Hachet, O., et al., Frequency and predictors of stroke after
acute myocardial infarction: specific aspects of in-hospital and
postdischarge events. Stroke, 2014. 45 (12): p. 3514-20.
16. Tamer Owais, A.F., Mohamed Adel, Martin Breuer, Jurgen Fuchs,
Bernward Lauer, Thomas Kuntze, Timing and Outcome of Coronary
Artery Bypass Grafting in STEMI: On-Pump and off-Pump Dilemma. Journal
of Cardiology & Current Research, 2017.
17. Violette, P.D., et al., A cost analysis of nonelective
coronary artery bypass graft surgery. J Card Surg, 2006.21 (6): p. 621-7.
18. Sun, L.Y., et al., Long-term Outcomes in Patients With
Severely Reduced Left Ventricular Ejection Fraction Undergoing
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.2020. 5 (6): p. 631-641.
19. Mølstad, P., R. Moer, and O. Rødevand, Long-term survival
after coronary bypass surgery and percutaneous coronary intervention.Open Heart, 2016. 3 (2): p. e000489.
20. Nichols, E.L., et al., Optimal Timing From Myocardial
Infarction to Coronary Artery Bypass Grafting on Hospital Mortality.Ann Thorac Surg, 2017. 103 (1): p. 162-171.
21. Gu, Y.L., et al., Role of coronary artery bypass grafting
during the acute and subacute phase of ST-elevation myocardial
infarction. Netherlands heart journal : monthly journal of the
Netherlands Society of Cardiology and the Netherlands Heart Foundation,
2010. 18 (7-8): p. 348-354.
22. Grothusen, C., et al., Outcome of Stable Patients With Acute
Myocardial Infarction and Coronary Artery Bypass Surgery Within
48 Hours: A Single-Center, Retrospective Experience. Journal of the
American Heart Association, 2017. 6 (10): p. e005498.
23. Davierwala Piroze, M., et al., Does Timing of Coronary Artery
Bypass Surgery Affect Early and Long-Term Outcomes in Patients With
Non–ST-Segment–Elevation Myocardial Infarction? Circulation, 2015.132 (8): p. 731-740.
24. Parikh, S.V., et al., Timing of in-hospital coronary artery
bypass graft surgery for non-ST-segment elevation myocardial infarction
patients results from the National Cardiovascular Data Registry ACTION
Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes
Network Registry-Get With The Guidelines) , in JACC Cardiovasc
Interv . 2010, 2010 American College of Cardiology Foundation. Published
by Elsevier Inc: United States. p. 419-27.
25. Ha, L.D., et al., Early versus delayed coronary artery bypass
graft surgery for patients with non-ST elevation myocardial infarction.Coron Artery Dis, 2017. 28 (8): p. 670-674.
26. Assmann, A., et al., Appropriate timing of coronary artery
bypass grafting after acute myocardial infarction. Thorac Cardiovasc
Surg, 2012. 60 (7): p. 446-51.
27. Wu, C., et al., Risk Score for Predicting Long-Term Mortality
After Coronary Artery Bypass Graft Surgery. Circulation, 2012.125 (20): p. 2423-2430.
28. Farkouh, M.E., et al., Strategies for Multivessel
Revascularization in Patients with Diabetes. New England Journal of
Medicine, 2012. 367 (25): p. 2375-2384.
29. Kapur, A., et al., The Coronary Artery Revascularisation in
Diabetes (CARDia) trial: background, aims, and design. Am Heart J,
2005. 149 (1): p. 13-9.
30. Group, B.D.S., A Randomized Trial of Therapies for Type 2
Diabetes and Coronary Artery Disease. New England Journal of Medicine,
2009. 360 (24): p. 2503-2515.
31. Abdallah, M.S., et al., Quality of life after PCI vs CABG
among patients with diabetes and multivessel coronary artery disease: a
randomized clinical trial. Jama, 2013. 310 (15): p. 1581-90.
32. NICE, Unstable Angina and NSTEMI: the early management of
unstable angina and non-ST-segment-elevation myocardial infarction.
Clinical guideline 94 . 2013. p. 31, 169.
33. Cardiology, E.S.o., Guidelines on myocardial
revascularization . 2018.
34. NICE, Myocardial infarction with ST-segment elevation: the
acute management of myocardial infarction withST-segment elevation.
Clinical guideline 167 . 2013.
35. Hillis, L.D., et al., 2011 ACCF/AHA Guideline for Coronary
Artery Bypass Graft Surgery. A report of the American College of
Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines. Developed in collaboration with the American Association for
Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and
Society of Thoracic Surgeons. J Am Coll Cardiol, 2011. 58 (24):
p. e123-210.
36. Hu, D., et al., Acute Coronary Syndrome Risk Prediction Based
on GRACE Risk Score. Stud Health Technol Inform, 2017. 245 : p.
398-402.
37. society, B.c., Myocardial Ischaemia National Audit Project
(MINAP) . 2019.
38. Gale, C.P., et al., Resolving inequalities in care? Reduced
mortality in the elderly after acute coronary syndromes. The Myocardial
Ischaemia National Audit Project 2003-2010. Eur Heart J, 2012.33 (5): p. 630-9.
39. Toleva, O., et al., Practice patterns and clinical outcomes
among non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
patients presenting to primary and tertiary hospitals: insights from the
EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.Catheter Cardiovasc Interv, 2014. 84 (6): p. 934-42.
40. Hall, M., et al., Association of Clinical Factors and
Therapeutic Strategies With Improvements in Survival Following
Non-ST-Elevation Myocardial Infarction, 2003-2013. JAMA, 2016.316 (10): p. 1073-82.
41. Lee, D.C., et al., Appropriate timing of surgical intervention
after transmural acute myocardial infarction. J Thorac Cardiovasc Surg,
2003. 125 (1): p. 115-9; discussion 119-20.
42. Weiss, E.S., et al., Optimal timing of coronary artery bypass
after acute myocardial infarction: a review of California discharge
data. J Thorac Cardiovasc Surg, 2008. 135 (3): p. 503-11,
511.e1-3.
43. Mehta, S.R., et al., Early versus delayed invasive
intervention in acute coronary syndromes. N Engl J Med, 2009.360 (21): p. 2165-75.
44. Milasinovic, D., et al., Three-Year Impact of Immediate
Invasive Strategy in Patients With Non-ST-Segment Elevation Myocardial
Infarction (from the RIDDLE-NSTEMI Study). Am J Cardiol, 2018.122 (1): p. 54-60.
45. Montalescot, G., et al., Effect of prasugrel pre-treatment
strategy in patients undergoing percutaneous coronary intervention for
NSTEMI: the ACCOAST-PCI study. J Am Coll Cardiol, 2014.64 (24): p. 2563-2571.
46. Farkouh, M.E., et al., Impact of Chronic Kidney Disease on
Outcomes of Myocardial Revascularization in Patients With Diabetes. J
Am Coll Cardiol, 2019. 73 (4): p. 400-411.
47. Najafi, M., M. Sheikhvatan, and S.H. Mortazavi, Do
preoperative pulmonary function indices predict morbidity after coronary
artery bypass surgery? Annals of cardiac anaesthesia, 2015.18 (3): p. 293-298.
48. Kosmidou, I., et al., C-reactive protein and prognosis after
percutaneous coronary intervention and bypass graft surgery for left
main coronary artery disease: Analysis from the EXCEL trial. Am Heart
J, 2019. 210 : p. 49-57.
49. Thielmann, M., et al., Predictors and outcomes of coronary
artery bypass grafting in ST elevation myocardial infarction. Ann
Thorac Surg, 2007. 84 (1): p. 17-24.
50. Ng, V.G., et al., The prognostic importance of left
ventricular function in patients with ST-segment elevation myocardial
infarction: the HORIZONS-AMI trial. European heart journal. Acute
cardiovascular care, 2014. 3 (1): p. 67-77.
51. Yang, T., et al., Myocardial scar identified by magnetic
resonance imaging can predict left ventricular functional improvement
after coronary artery bypass grafting. PloS one, 2013. 8 (12):
p. e81991-e81991.
52. Sheriff, M.J., et al., Cardiac Magnetic Resonance Imaging
Predictors of Short-Term Outcomes after High Risk Coronary Surgery.2016. 25 (6): p. 613-619.
53. Nucifora, G. and J.B. Selvanayagam, Cardiac Magnetic Resonance
Imaging Before Coronary Artery Bypass Graft Surgery: Is It Ready for
Risk Stratification? 2016. 25 (6): p. 535-537.
54. Hausenloy, D.J., et al., The effect of cyclosporin-A on
peri-operative myocardial injury in adult patients undergoing coronary
artery bypass graft surgery: a randomised controlled clinical trial.Heart, 2014. 100 (7): p. 544.